Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis

por Aaroe, Ashley, Kurzrock, Razelle, Goyal, Gaurav, Goodman, Aaron M., Patel, Harsh, Ruan, Gordon, Ulaner, Gary, Young, Jason, Li, Ziyi, Dustin, Derek, Go, Ronald S., Diamond, Eli L., Janku, Filip
Publicado 2023

RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer

por Dustin, Derek, Gu, Guowei, Beyer, Amanda R., Herzog, Sarah K., Edwards, David G., Lin, Hangqing, Gonzalez, Thomas L., Grimm, Sandra L., Coarfa, Cristian, Chan, Doug W., Kim, Beom-Jun, De La O, Jean-Paul, Ellis, Matthew J., Liu, Dan, Li, Shunqiang, Welm, Alana L., Fuqua, Suzanne A. W.
Publicado 2020

Hormonal Modulation of ESR1 Mutant Metastasis

por Gu, Guowei, Tian, Lin, Herzog, Sarah K., Rechoum, Yassine, Gelsomino, Luca, Gao, Meng, Du, Lili, Kim, Jin-Ah, Dustin, Derek, Lo, Hin Ching, Beyer, Amanda R., Edwards, David G., Gonzalez, Thomas, Tsimelzon, Anna, Huang, Helen J., Fernandez, Natalie M., Grimm, Sandra L., Hilsenbeck, Susan G., Liu, Dan, Xu, Jun, Alaniz, Alyssa, Li, Shunqiang, Mills, Gordon B., Janku, Filip, Kittler, Ralf, Zhang, Xiang H.-F., Coarfa, Cristian, Foulds, Charles E., Symmans, W. Fraser., Andò, Sebastiano, Fuqua, Suzanne A.W.
Publicado 2020